Giunta, Emilio Francesco
Barra, Giusi
De Falco, Vincenzo
Argenziano, Giuseppe
Napolitano, Stefania
Vitale, Pasquale
Zanaletti, Nicoletta
Terminiello, Marinella
Martinelli, Erika
Morgillo, Floriana
Ciardiello, Davide
De Palma, Raffaele
Ciardiello, Fortunato
Troiani, Teresa
Article History
Received: 13 January 2020
Accepted: 10 August 2020
First Online: 19 October 2020
Competing interests
: EM: advisory boards: Amgen, Astra-Zeneca, Bayer, Merck, Pierre Fabre, Sanofy, Servier; consultant: ESMO. FM: advisory board for Lilly, MSD. FC: advisory boards: Amgen, Bayer, BMS, Cellgene, Lilly, Merck, Pfizer, Roche, Sanofi, Servier; institutional research grants: Amgen, AstraZeneca, Bayer, Merck, Roche, Takeda. TT: institutional research grants: Bayer, Merck, Novartis, Roche, Sanofi, Servier. The other authors have no conflict of interest to declare.